According to Bioniche and press reports, the USDA has agreed to grant a conditional license to Bioniche for its E. coli O157:H7 Cattle Vaccine.
Is this the “silver bullet” to solve the recent uptick in E. coli recalls and human illnesses? I have had the opportunity to meet with Bioniche scientists and executives over

The Associated Press reports that the families of two children sickened by the
"Seminar in Seattle" – Registration Below. Few subjects draw more immediate attention or concern than the safety of the food we eat. Recent years have included a plethora of food warnings and recalls, raising new questions about the quality and integrity of our existing system for assuring food safety. Seattle was the epicenter of the
E. sakazakii is a rare cause of bloodstream and central nervous system infections. The organism has also been associated with necrotizing enterocolitis; however, it has not been firmly established as a causative agent. Reported outcomes are often severe: seizures; brain abscess; hydrocephalus; developmental delay; and death in as many as 40%–80% of cases. Premature infants are thought to be at greater risk than more mature infants, other children, or adults, and outbreaks of disease have occurred in hospital units for newborns. (2).jpg)
Lauran Neergaard of the
The